This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/news/517181-international-coalition-fast-track-covid-vaccines-variants/
The article has changed 3 times. There is an RSS feed of changes available.
| Version 0 | Version 1 |
|---|---|
| International coalition of regulatory authorities agree to fast-track modified Covid-19 vaccines for variants | International coalition of regulatory authorities agree to fast-track modified Covid-19 vaccines for variants |
| (6 months later) | |
| The ACCESS Consortium, an international coalition of regulatory authorities, has announced it will fast-track the approval of modified Covid-19 vaccines for new variants of the virus, avoiding the normal lengthy approval process. | The ACCESS Consortium, an international coalition of regulatory authorities, has announced it will fast-track the approval of modified Covid-19 vaccines for new variants of the virus, avoiding the normal lengthy approval process. |
| In an announcement on Thursday, ACCESS Consortium revealed that it will fast-track any modified vaccines if manufacturers “provide robust evidence” to help get doses of effective jabs to the public quickly. | In an announcement on Thursday, ACCESS Consortium revealed that it will fast-track any modified vaccines if manufacturers “provide robust evidence” to help get doses of effective jabs to the public quickly. |
| “Our priority is to get effective vaccines to the public in as short a time as possible, without compromising on safety,” MHRA’s chief scientific officer, Dr. Christian Schneider, said in a statement. | “Our priority is to get effective vaccines to the public in as short a time as possible, without compromising on safety,” MHRA’s chief scientific officer, Dr. Christian Schneider, said in a statement. |
| Addressing potential concerns that a faster regulatory process would impact the safety of the vaccines, the MHRA said that no vaccine would be approved unless it met the “high standards” of “quality and effectiveness” that are required. | Addressing potential concerns that a faster regulatory process would impact the safety of the vaccines, the MHRA said that no vaccine would be approved unless it met the “high standards” of “quality and effectiveness” that are required. |
| While existing vaccines were developed to protect against earlier forms of Covid-19, it is believed that they should still provide some protection against mutated forms of coronavirus, such as the Brazilian, Kent, or South African strains. | While existing vaccines were developed to protect against earlier forms of Covid-19, it is believed that they should still provide some protection against mutated forms of coronavirus, such as the Brazilian, Kent, or South African strains. |
| Countries, like the UK, already fast-track modified versions of the flu vaccine on an annual basis to ensure that it keeps up with the seasonal virus, so it’s expected that updated versions of the coronavirus vaccine would be approved using a similar process. | Countries, like the UK, already fast-track modified versions of the flu vaccine on an annual basis to ensure that it keeps up with the seasonal virus, so it’s expected that updated versions of the coronavirus vaccine would be approved using a similar process. |
| ACCESS Consortium was originally formed in 2007 by Australia, Canada, Singapore, and Switzerland to increase global cooperation to ensure patients have quick access to high quality, safe and effective medical products. The UK Medicines and Healthcare products Regulatory Agency joined in 2020. | ACCESS Consortium was originally formed in 2007 by Australia, Canada, Singapore, and Switzerland to increase global cooperation to ensure patients have quick access to high quality, safe and effective medical products. The UK Medicines and Healthcare products Regulatory Agency joined in 2020. |
| Like this story? Share it with a friend! | Like this story? Share it with a friend! |
| Dear readers and commenters, | |
| We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system. | |
| Sorry for the inconvenience, and looking forward to your future comments, | |
| RT Team. |